Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Completed 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 19OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2Dermatologic 2Breast 1

Conditions

Breast Neoplasms 9481Neoplasms 6589Prostatic Neoplasms 4399Colorectal Neoplasms 3978Lung Neoplasms 3644Carcinoma, Non-Small-Cell Lung 3585Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Leukemia, Myeloid, Acute 2265Multiple Myeloma 2121Stomach Neoplasms 2109Neoplasm Metastasis 1911Head and Neck Neoplasms 1870Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Brain Neoplasms 1702Rectal Neoplasms 1676Melanoma 1656Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1308Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Vaccinia × Clear all
NCT07001592 2025-06-03

RIOT3

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
18 enrolled
Gastrointestinal

Esophageal Neoplasms, Liver Neoplasms, Stomach Neoplasms, Vaccinia

NCT04022148 2019-07-19

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

University of Fukui

Unknown
2,800 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vaccinia

NCT00574977 2015-12-28

Safety Study of Modified Vaccinia Virus to Cancer

University of Pittsburgh

Phase 1 Completed
26 enrolled
BreastDermatologicGastrointestinal

Adenocarcinoma, Breast Neoplasms, Liver Neoplasms, Melanoma, Neoplasms, Vaccinia, Virus Diseases, Colorectal Neoplasms, Neoplasms, Squamous Cell

NCT02017678 2014-09-17

Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin

Mount Sinai Hospital, Canada

Phase 2 Withdrawn
Gynecologic

Carcinoma, Ovarian Neoplasms, Vaccinia

NCT00116597 2009-12-02

Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma

University Hospital, Basel, Switzerland

Phase 1/2 Completed
15 enrolled
Dermatologic

Melanoma, Neoplasms, Vaccinia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡